Infections In Medicine
The drug maker added biotechs Optimer and Trius to the fold, a bid to dominate in hard-to-treat infections.
GSK and the US Department of Health and Human Services inked a deal to fund development of new antibiotics, an area where clinicians face a dearth of new options.
CMPMedica ceased publication on two of its titles--Infections in Medicine and AIDS Reader--due to a continuing decline in print advertising sales.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.